-0.94 | -16.32%
| Price and Volume | |
|---|---|
| Recent Price | 4.82 |
| 52 Week High | 10.75 |
| 52 Week Low | 2.29 |
| Avg. Daily Vol. (Mil) | 0.20 |
| Beta (3 year) | 1.14 |
| Share Related Items | |
| Mkt Cap (Mil) | 74.65 |
| Shares Out (Mil) | 15.49 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 8.80 |
| Current Ratio | 9.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 68.20 |
| Price/Sales | 3.82 |
| Price/Book | 5.08 |
| Price/Cash Flow | 45.70 |
| Per Share Data | |
| Earnings | 0.07 |
| Sales | 1.26 |
| Book Value | 0.95 |
| Cash Flow | 0.11 |
| Business Summary | |
|---|---|
| Genetic Technologies Ltd. is a biotechnology company focuses on expanding its genetic testing and reproductive service businesses in the Asia-Pacific region. | |
| General Information | |
| 60-66 Hanover Street
Fitzroy, VI 3065 |
|
| 1.0 | |
| www.gtglabs.com.au | |
| Industry : Diversified Services | |
| Sector: Services | |
| Employees: 58 | |
| CEO: Dr. Paul D.R. MacLeman | |
| Short Interest | |
| Current Month (Mil) | 0.05 |
| Previous Month (Mil) | 0.04 |
| Short Interest Ratio (Days) | 2.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | 0.00 |
| Return on Investments | n.a. |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 5.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet